The Application of CAR-T Cells in Haematological Malignancies

Chimeric antigen receptor (CAR)-T cells (CART) remain one of the most advanced and promising forms of adoptive T-cell immunotherapy. CART represent autologous, genetically engineered T lymphocytes expressing CAR, i.e. fusion proteins that combine components and features of T cells as well as antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Skorka, Katarzyna, Ostapinska, Katarzyna, Malesa, Aneta, Giannopoulos, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647970/
https://www.ncbi.nlm.nih.gov/pubmed/33156409
http://dx.doi.org/10.1007/s00005-020-00599-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647970/
https://www.ncbi.nlm.nih.gov/pubmed/33156409
http://dx.doi.org/10.1007/s00005-020-00599-x

Ejemplares similares